PORTLAND, IA, UNITED STATES, January 9, 2025 /EINPresswire / -- The factors that are anticipated to impede the growth of the global nucleic acid therapeutics market during the forecast period include, ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.TRc4SPmX.js ...

Maravai LifeSciences Holdings said Wednesday it expects to report full-year revenue for 2024 near the midpoint of its most recent outlook. The San Diego company has guided for full-year revenue ...

Professor Kevin J. Zwezdaryk and Chandler H. Monk discuss CRISPR and diagnostics, focusing on the development of a portable ...

How to Know Whether You Are Infected or Not? Scroll down to learn the top tests that can help detect Human Metapneumovirus.

The "Home Diagnostics Market: Strategies and Trends - Forecasts by Application, by Channel, by Technology and by Country, with Market Analysis and Executive Guides" report has been added to ...

Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm's expertise in customized nucleic ...

Principal Financial Group Inc. lessened its stake in shares of Qiagen (NYSE:QGEN – Free Report) by 12.0% in the 3rd quarter, ...

Morgan Stanley reiterated their equal weight rating on shares of Qiagen (NYSE:QGEN – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The firm currently has a ...

Increases speed to market for drug developers working on nucleic acid therapeutics.